In refiling $16.5B Catalent buyout pitch, Novo gives FTC more time for review fkansteiner Fri, 04/05/2024 – 15:15 More: In refiling .5B Catalent buyout pitch, Novo gives FTC more time for review Source: fierce
read moreAs Humira biosim sales languish, Boehringer Ingelheim plots layoffs in pivot to hybrid marketing model fkansteiner Fri, 04/05/2024 – 11:07 More: As Humira biosim sales languish, Boehringer Ingelheim plots layoffs in pivot to hybrid marketing model Source: fierce
read moreBristol Myers’ Abecma wins FDA nod in earlier multiple myeloma with updated boxed warning on secondary cancer aliu Fri, 04/05/2024 – 11:06 More: Bristol Myers’ Abecma wins FDA nod in earlier multiple myeloma with updated boxed warning on secondary cancer
read moreHouse committee to press FDA Commissioner Robert Califf on shortage oversight, other issues zbecker Fri, 04/05/2024 – 09:54 More: House committee to press FDA Commissioner Robert Califf on shortage oversight, other issues Source: fierce
read moreAstraZeneca’s Imfinzi tackles another type of lung cancer with latest trial win esagonowsky Fri, 04/05/2024 – 09:20 More: AstraZeneca’s Imfinzi tackles another type of lung cancer with latest trial win Source: fierce
read moreHoxa9 and b-catenin molecules are a rare population of self-renewing HSCs found in bone marrow More: Key mechanism controlling bone marrow stem cells could lead to new therapies Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals